Harrow (HROW) Non-Current Assets (2010 - 2026)

Harrow's (HROW) quarterly Non-Current Assets came in at $193.2 million in Q1 2026, down 0.76% year-on-year from $194.6 million in Q1 2025, and up 2.89% quarter-over-quarter from $187.7 million in Q4 2025.

Harrow (HROW) Non-Current Assets (2010 - 2026) Analysis & Trends

Harrow's Non-Current Assets history runs 16 years deep, the most recent figure standing at $193.2 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 0.76% year-over-year to $193.2 million in Q1 2026; TTM through Mar 2026 was $756.5 million, a 1.2% decrease from a year earlier, with the FY2025 full-year figure at $187.7 million, down 5.81% from the prior year.
  • Non-Current Assets improved to $193.2 million in Q1 2026 per HROW's latest filing, from $187.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $204.5 million in Q3 2024 and bottomed at $107000.0 in Q4 2022.
  • The 5-year median for Non-Current Assets is $170.1 million (2024), against an average of $110.0 million.
  • Across the five-year window, Non-Current Assets plunged 74.03% in 2022 and soared 161285.05% in 2023, its largest moves.
  • Year by year, Non-Current Assets stood at $107000.0 in 2022, then surged by 161285.05% to $172.7 million in 2023, then advanced by 15.43% to $199.3 million in 2024, then fell by 5.81% to $187.7 million in 2025, then increased by 2.89% to $193.2 million in 2026.
  • Per Business Quant, the three latest HROW Non-Current Assets figures stand at $193.2 million (Q1 2026), $187.7 million (Q4 2025), and $185.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn 193.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 193.16 Mn
Dec 31, 2025 187.73 Mn
Sep 30, 2025 185.47 Mn
Jun 30, 2025 190.14 Mn
Mar 31, 2025 194.63 Mn
Dec 31, 2024 199.32 Mn
Sep 30, 2024 204.48 Mn
Jun 30, 2024 167.24 Mn
Mar 31, 2024 170.08 Mn
Dec 31, 2023 172.68 Mn
Sep 30, 2023 780,000.00
Jun 30, 2023 808,000.00
Mar 31, 2023 902,000.00
Dec 31, 2022 107,000.00
Sep 30, 2022 994,000.00
Jun 30, 2022 661,000.00
Mar 31, 2022 411,000.00
Dec 31, 2021 412,000.00
Sep 30, 2021 36,000.00
Jun 30, 2021 98,000.00